Design and implementation of the dual-center programming platform for ternary optical computer and electronic computer

被引:0
作者
Zhang, Sulan [1 ,2 ]
Fan, Xin [1 ]
Li, Shuang [3 ]
Liu, Jian [4 ,5 ]
Wang, Xiaolin [1 ]
Teng, Zi [1 ]
Zhang, Chunhua [1 ]
机构
[1] Jiaxing Univ, Sch Informat Sci & Engn, Jiaxing 314000, Zhejiang, Peoples R China
[2] Jiaxing Univ, Key Lab Med Elect & Digital Hlth Zhejiang Prov, Jiaxing 314000, Zhejiang, Peoples R China
[3] Shanghai Normal Univ, Coll Informat Mech & Elect Engn, Shanghai 200234, Peoples R China
[4] Shanghai Univ, Sch Comp Engn & Sci, Shanghai 200444, Peoples R China
[5] State Grid Chizhou Power Supply Co, 88 Jianshe West Rd, Chizhou 247000, Anhui, Peoples R China
来源
SCIENTIFIC REPORTS | 2024年 / 14卷 / 01期
基金
美国国家科学基金会;
关键词
Ternary optical computer (TOC); Ternary optical processor (TOP); Dual-center model; Programming platform; Application program; HEPATOCELLULAR-CARCINOMA; LIVER; TRIMETHYLATION; IDENTIFICATION; CHROMATIN; JMJD2B;
D O I
10.1038/s41598-024-75976-z
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
In order to utilize the advantages of optical computing and promote the application and popularization of Ternary Optical Computer (TOC), this paper proposes a dual-center programming model consisting of electronic processor and optical processor, presents the theory and technologies of the dual-center model in detail, and for the first time explains the SAN ZHI GUANG (SZG) file chain technology, gives the implementation method of the dual-center model. The model tries to effectively manage the resources of optical processor and solve the problem of the distance and network connection mode of using the TOC. Experimental results show that the dual-center model is correct and the implementation method is feasible. It can improve the usability of the TOC and further simplify the TOC programming process, and makes common users apply the TOC and electronic computer to work cooperatively for the same task.
引用
收藏
页数:15
相关论文
共 40 条
  • [1] A pilot study in patients with established advanced liver fibrosis using pirfenidone
    Armendariz-Borunda, J.
    Islas-Carbajal, M. C.
    Meza-Garcia, E.
    Rincon, A. R.
    Lucano, S.
    Sandoval, A. S.
    Salazar, A.
    Berumen, J.
    Alvarez, A.
    Covarrubias, A.
    Arechiga, G.
    Garcia, L.
    [J]. GUT, 2006, 55 (11) : 1663 - 1665
  • [2] Regulation of chromatin by histone modifications
    Bannister, Andrew J.
    Kouzarides, Tony
    [J]. CELL RESEARCH, 2011, 21 (03) : 381 - 395
  • [3] Fluorinated derivatives of pyridine-2,4-dicarboxylate are potent inhibitors of human 2-oxoglutarate dependent oxygenases
    Brewitz, Lennart
    Nakashima, Yu
    Tumber, Anthony
    Salah, Eidarus
    Schofield, Christopher J.
    [J]. JOURNAL OF FLUORINE CHEMISTRY, 2021, 247
  • [4] Pirfenidone prevents and reverses hepatic insulin resistance and steatohepatitis by polarizing M2 macrophages
    Chen, Guanliang
    Ni, Yinhua
    Nagata, Naoto
    Liang Xu
    Fen Zhuge
    Nagashimada, Mayumi
    Kaneko, Shuichi
    Ota, Tsuguhito
    [J]. LABORATORY INVESTIGATION, 2019, 99 (09) : 1335 - 1348
  • [5] KDM4B protects against obesity and metabolic dysfunction
    Cheng, Yingduan
    Yuan, Quan
    Vergnes, Laurent
    Rong, Xin
    Youn, Ji Youn
    Li, Jiong
    Yu, Yongxin
    Liu, Wei
    Cai, Hua
    Lin, Jiandie D.
    Tontonoz, Peter
    Hong, Christine
    Reue, Karen
    Wang, Cun-Yu
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2018, 115 (24) : E5566 - E5575
  • [6] Structure-based design of antiviral drug candidates targeting the SARS-CoV-2 main protease
    Dai, Wenhao
    Zhang, Bing
    Jiang, Xia-Ming
    Su, Haixia
    Li, Jian
    Zhao, Yao
    Xie, Xiong
    Jin, Zhenming
    Peng, Jingjing
    Liu, Fengjiang
    Li, Chunpu
    Li, You
    Bai, Fang
    Wang, Haofeng
    Cheng, Xi
    Cen, Xiaobo
    Hu, Shulei
    Yang, Xiuna
    Wang, Jiang
    Liu, Xiang
    Xiao, Gengfu
    Jiang, Hualiang
    Rao, Zihe
    Zhang, Lei-Ke
    Xu, Yechun
    Yang, Haitao
    Liu, Hong
    [J]. SCIENCE, 2020, 368 (6497) : 1331 - +
  • [7] Pirfenidone modifies hepatic miRNAs expression in a model of MAFLD/NASH
    Escutia-Gutierrez, Rebeca
    Samael Rodriguez-Sanabria, J.
    Alejandra Monraz-Mendez, C.
    Garcia-Banuelos, Jesus
    Santos-Garcia, Arturo
    Sandoval-Rodriguez, Ana
    Armendariz-Borunda, Juan
    [J]. SCIENTIFIC REPORTS, 2021, 11 (01)
  • [8] Treatment with pirfenidone for two years decreases fibrosis, cytokine levels and enhances CB2 gene expression in patients with chronic hepatitis C
    Flores-Contreras, Lucia
    Sandoval-Rodriguez, Ana S.
    Mena-Enriquez, Mayra G.
    Lucano-Landeros, Silvia
    Arellano-Olivera, Inmaculada
    Alvarez-Alvarez, Arnulfo
    Guadalupe Sanchez-Parada, M.
    Armendariz-Borunda, Juan
    [J]. BMC GASTROENTEROLOGY, 2014, 14
  • [9] Jmjd2b antagonizes H3K9 trimethylation at pericentric heterochromatin in mammalian cells
    Fodor, Barna D.
    Kubicek, Stefan
    Yonezawa, Masato
    O'Sullivan, Roderick J.
    Sengupta, Roopsha
    Perez-Burgos, Laura
    Opravil, Susanne
    Mechtler, Karl
    Schotta, Gunnar
    Jenuwein, Thomas
    [J]. GENES & DEVELOPMENT, 2006, 20 (12) : 1557 - 1562
  • [10] A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis
    Harrison, Stephen A.
    Bedossa, Pierre
    Guy, Cynthia D.
    Schattenberg, Joern M.
    Loomba, Rohit
    Taub, Rebecca
    Labriola, Dominic
    Moussa, Sam E.
    Neff, Guy W.
    Rinella, Mary E.
    Anstee, Quentin M.
    Abdelmalek, Manal F.
    Younossi, Zobair
    Baum, Seth J.
    Francque, Sven
    Charlton, Michael R.
    Newsome, Philip N.
    Lanthier, Nicolas
    Schiefke, Ingolf
    Mangia, Alessandra
    Pericas, Juan M.
    Patil, Rashmee
    Sanyal, Arun J.
    Noureddin, Mazen
    Bansal, Meena B.
    Alkhouri, Naim
    Castera, Laurent
    Rudraraju, Madhavi
    Ratziu, Vlad
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2024, 390 (06) : 497 - 509